Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 AJANTA PHARMA   ACTAVIS
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
ACTAVIS
Dec-18
AJANTA PHARMA/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs1,42616,126-   
Low Rs1,06210,818-   
Sales per share (Unadj.) Rs297.23,955.8-  
Earnings per share (Unadj.) Rs46.7-1,274.2-  
Cash flow per share (Unadj.) Rs57.1416.9-  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.116,315.7-  
Shares outstanding (eoy) m125.91332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.23.4 122.9%   
Avg P/E ratio x26.6-10.6 -252.0%  
P/CF ratio (eoy) x21.832.3 67.4%  
Price / Book Value ratio x4.60.8 560.0%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,6384,480,758 3.5%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m7,8510-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m37,4261,315,689 2.8%  
Other income Rs m98625,160 3.9%   
Total revenues Rs m38,4131,340,849 2.9%   
Gross profit Rs m7,83334,478 22.7%  
Depreciation Rs m1,308562,428 0.2%   
Interest Rs m5875,923 0.1%   
Profit before tax Rs m7,453-578,713 -1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m1,573-7,334 -21.4%   
Profit after tax Rs m5,880-423,784 -1.4%  
Gross profit margin %20.92.6 798.6%  
Effective tax rate %21.11.3 1,665.2%   
Net profit margin %15.7-32.2 -48.8%  
BALANCE SHEET DATA
Current assets Rs m28,252539,627 5.2%   
Current liabilities Rs m11,393477,372 2.4%   
Net working cap to sales %45.04.7 952.0%  
Current ratio x2.51.1 219.4%  
Inventory Days Days6620 336.2%  
Debtors Days Days1066 15.5%  
Net fixed assets Rs m18,707148,929 12.6%   
Share capital Rs m2530-   
"Free" reserves Rs m33,6240-   
Net worth Rs m33,8775,426,601 0.6%   
Long term debt Rs m131,910,903 0.0%   
Total assets Rs m47,0478,483,012 0.6%  
Interest coverage x128.6-6.6 -1,942.1%   
Debt to equity ratio x00.4 0.1%  
Sales to assets ratio x0.80.2 512.9%   
Return on assets %12.6-4.1 -307.8%  
Return on equity %17.4-7.8 -222.3%  
Return on capital %22.2-4.8 -457.8%  
Exports to sales %59.90-   
Imports to sales %11.50-   
Net fx Rs m18,1270-   
CASH FLOW
From Operations Rs m7,918470,046 1.7%  
From Investments Rs m-5,596258,229 -2.2%  
From Financial Activity Rs m-1,079-806,740 0.1%  
Net Cashflow Rs m1,243-78,073 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare AJANTA PHARMA With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare AJANTA PHARMA With: VIVO BIO TECH  PANACEA BIOTECH  KABRA DRUGS  RPG LIFE SCIENCES  VALIANT LABORATORIES LTD.  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.